5-N-Substituted-2-(substituted benzenesulphonyl) glutamines as antitumor agents. Part II: synthesis, biological

Soma Samanta1, K Srikanth, Suchandra Banerjee

  • 1Department of Pharmaceutical Technology, PO Box 17020, Jadavpur University, Kolkata-700032, India.

Insights

Researchers synthesized novel glutamine analogues to combat cancer, a major disease. A Quantitative Structure-Activity Relationship (QSAR) study identified key structural features for enhanced antitumor activity.

Area of Science:

  • Biochemistry
  • Medicinal Chemistry
  • Oncology

Background:

  • Cancer cells exhibit high demand for glutamine, utilizing it for nucleic acid and protein synthesis.
  • Glutamine acts as a crucial nitrogen source for tumor growth, making it a target for anticancer drug development.

Purpose of the Study:

  • To design and synthesize novel glutamine analogues as potential anticancer agents.
  • To investigate the structure-activity relationships of these analogues for improved antitumor efficacy.

Main Methods:

  • Synthesis of 17 new 5-N-Substituted-2-(substituted benzenesulphonyl) glutamines.
  • Antitumor activity screening of 53 glutamine analogues using tumor cell count inhibition.
  • Quantitative Structure-Activity Relationship (QSAR) analysis incorporating physicochemical and topological parameters.

Main Results:

  • Several synthesized glutamine analogues demonstrated significant antitumor activity.
  • QSAR analysis revealed that steric effects on the aromatic ring positively influence activity.
  • Specific substitutions, including n-butyl on the aliphatic side chain and at atom 12, were identified as crucial for activity.

Conclusions:

  • Novel glutamine analogues show promise as anticancer agents.
  • Structural modifications guided by QSAR can enhance the effectiveness of glutamine-based anticancer therapies.
  • Targeting cancer cell glutamine metabolism remains a viable strategy for drug discovery.